Evidence map›Paper›PMID 32850878›Full record

ArticleFrontiers in medicine2020

The Potential Innovative Use of Bacteriophages Within the DAC

Tristan Ferry, Cécile Batailler, Charlotte Petitjean, Joseph Chateau, Cindy Fevre, Emmanuel Forestier, Sophie Brosset, Gilles Leboucher, Camille Kolenda, Frédéric Laurent and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 4 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 4 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. [Phage therapy in Germany-Update 2025].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025
    Review
  15. Septic arthritis - symptoms, diagnosis and new therapy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Tristan FerryService des Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
Cécile BataillerUniversité Claude Bernard Lyon 1, Lyon, France.
Charlotte PetitjeanPherecydes Pharma, Romainville, France.
Joseph ChateauService de Chirurgie Plastique et Reconstructrice, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
Cindy FevrePherecydes Pharma, Romainville, France.
Emmanuel ForestierService de Maladies Infectieuses, Centre Hospitalier Metropole Savoie, Chambéry, France.
Sophie BrossetService de Chirurgie Plastique et Reconstructrice, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
Gilles LeboucherPharmacie, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
Camille KolendaUniversité Claude Bernard Lyon 1, Lyon, France.
Frédéric LaurentUniversité Claude Bernard Lyon 1, Lyon, France.
Sébastien LustigUniversité Claude Bernard Lyon 1, Lyon, France.
Hôpital de la Croix-Rousse · FRHospices Civils de Lyon · FRCentre Hospitalier Métropole Savoie · FRCentre National de la Recherche Scientifique · FRInserm · FRUniversité Claude Bernard Lyon 1 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infection is the most dramatic complication in patients with knee megaprosthesis. Its management is more complex in comparison with patients with primary arthroplasty, with a high risk of relapse. Lytic bacteriophages are considered to have a high potential in patients with prosthetic joint infection as it has been demonstrated that they have a synergistic anti-biofilm activity with antibiotics. The Defensive Antibacterial Coating (DAC®) hydrogel is a hydrogel available in the market that has been designed to prevent the adherence of bacteria on a prosthetic joint and to have the ability to transport and release anti-bacterial substances such as antibiotics. We report here the case of a patient with a catastrophic relapsing

Indexed as

bacteriophagehydrogelmegaprosthesisphage therapyprosthetic joint infection

Identifiers

PMID32850878
PMCPMC7410981
OpenAlexW3046551743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.